Dr. Mistry on Gaucher Disease Entering a New Era

Dr. Pramod Mistry Provides a 4.5-Year Update of the ENGAGE TrialПодробнее

Meet Dr. Pramod MistryПодробнее

Dr. Pramod Mistry discusses biomarkers as they pertain to patients with type 1 Gaucher diseaseПодробнее

Which Patients with Gaucher Disease Switching to the Oral Treatment Option?Подробнее

Treating Gaucher Disease Type 3: A History LessonПодробнее

Yale Offers New Insights, Treatment, and Hope for Gaucher DiseaseПодробнее

Dr. Vivaldi on the Transformation of Gaucher DiseaseПодробнее

Dr. Mistry Explains the History of Gaucher DiseaseПодробнее

Dr. Pramod Mistry Discusses the Link Between Lipds and the Origin of MyelomasПодробнее

Dr. Lukina Discusses Timely Gaucher Disease DiagnosisПодробнее

Journey to Diagnosis - Patient StoriesПодробнее

Spot the Early Signs of Gaucher DiseaseПодробнее

Cerdelga for Gaucher Disease – Summary of the Clinical EvidenceПодробнее

Yale Clinical Grand Rounds 10/4/22 | Dr. Pramod Mistry, MD, PhDПодробнее

Gaucher Disease: How a Rare Disease Provides a Window into Common Neurodegenerative DisordersПодробнее

Dr. Zimran Discusses Biomarkers in Gaucher DiseaseПодробнее

Meet Gastroenterologist Pramod Mistry, MBBS, PhD, FRCPПодробнее

Delayed Diagnosis Common in Gaucher DiseaseПодробнее

Diagnosing Mild Forms of Gaucher DiseaseПодробнее